FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021041107> ?p ?o ?g. }

• W2021041107 endingPage "377" @default.
• W2021041107 startingPage "371" @default.
• W2021041107 abstract "Hunter syndrome (mucopolysaccharidosis type II [MPS II], OMIM309900) is a rare X-linked lysosomal storage disorder caused by deficiency of the enzyme iduronate-2-sulphatase, resulting in accumulation of glycosaminoglycans (GAGs), multisystem organ failure and early death. Enzyme replacement therapy (ERT) with idursulfase is commercially available since 2007. Early access programs were established since 2005. However, limited information on the effects of ERT in young children is available to date. The aim of this analysis was therefore to determine the effects of ERT on patients younger than 5 years of age. We report data from six Spanish patients with confirmed Hunter syndrome who were younger than 5 years at the start of ERT, and had been treated with weekly intravenous infusions of idursulfase between 6 and 14 months. Baseline and treatment data were obtained from the Hunter Outcome Survey (HOS). HOS is an international database of MPS II patients on ERT or candidates to be treated, that collects data in a registry manner. HOS is supported by Shire Human Genetic Therapies, Inc. (Cambridge, MA, USA). At baseline, all patients showed neurological abnormalities, including ventriculomegaly, hydrocephaly, cerebral atrophy, perivascular changes and white matter lesions. Other signs and symptoms included thoracic deformity, otitis media, joint stiffness and hepatosplenomegaly, demonstrating that children under 5 years old can also be severely affected. ERT reduced urinary GAG levels, and reduced spleen (n = 2) and liver size (n = 1) after only 8 months. Height growth was maintained within the normal range during ERT. Joint mobility either stabilized or improved during ERT. In conclusion, this case series confirms the early onset of signs and symptoms of Hunter syndrome and provides the first evidence of ERT beneficial effects in patients less than 5 years of age. Similar efficacy and safety profiles to those seen in older children can be suggested, although further studies including a direct comparison with older patients would still be required." @default.
• W2021041107 created "2016-06-24" @default.
• W2021041107 creator A5011378291 @default.
• W2021041107 creator A5020434582 @default.
• W2021041107 creator A5044080822 @default.
• W2021041107 creator A5047343550 @default.
• W2021041107 creator A5047501466 @default.
• W2021041107 creator A5052626495 @default.
• W2021041107 creator A5062810233 @default.
• W2021041107 creator A5076973291 @default.
• W2021041107 date "2010-11-01" @default.
• W2021041107 modified "2023-10-16" @default.
• W2021041107 title "First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: Case observations from the Hunter Outcome Survey (HOS)" @default.
• W2021041107 cites W1598400863 @default.
• W2021041107 cites W1977323819 @default.
• W2021041107 cites W1989295722 @default.
• W2021041107 cites W1993027304 @default.
• W2021041107 cites W2003880883 @default.
• W2021041107 cites W2027292988 @default.
• W2021041107 cites W2029308033 @default.
• W2021041107 cites W2034511507 @default.
• W2021041107 cites W2034981978 @default.
• W2021041107 cites W2035947437 @default.
• W2021041107 cites W2058795042 @default.
• W2021041107 cites W2075876382 @default.
• W2021041107 cites W2093722439 @default.
• W2021041107 cites W2117500144 @default.
• W2021041107 cites W2128481859 @default.
• W2021041107 cites W2148045371 @default.
• W2021041107 doi "https://doi.org/10.1016/j.ejmg.2010.07.013" @default.
• W2021041107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20709629" @default.
• W2021041107 hasPublicationYear "2010" @default.
• W2021041107 type Work @default.
• W2021041107 sameAs 2021041107 @default.
• W2021041107 citedByCount "40" @default.
• W2021041107 countsByYear W20210411072012 @default.
• W2021041107 countsByYear W20210411072013 @default.
• W2021041107 countsByYear W20210411072014 @default.
• W2021041107 countsByYear W20210411072015 @default.
• W2021041107 countsByYear W20210411072016 @default.
• W2021041107 countsByYear W20210411072017 @default.
• W2021041107 countsByYear W20210411072018 @default.
• W2021041107 countsByYear W20210411072020 @default.
• W2021041107 countsByYear W20210411072021 @default.
• W2021041107 countsByYear W20210411072022 @default.
• W2021041107 countsByYear W20210411072023 @default.
• W2021041107 crossrefType "journal-article" @default.
• W2021041107 hasAuthorship W2021041107A5011378291 @default.
• W2021041107 hasAuthorship W2021041107A5020434582 @default.
• W2021041107 hasAuthorship W2021041107A5044080822 @default.
• W2021041107 hasAuthorship W2021041107A5047343550 @default.
• W2021041107 hasAuthorship W2021041107A5047501466 @default.
• W2021041107 hasAuthorship W2021041107A5052626495 @default.
• W2021041107 hasAuthorship W2021041107A5062810233 @default.
• W2021041107 hasAuthorship W2021041107A5076973291 @default.
• W2021041107 hasConcept C126322002 @default.
• W2021041107 hasConcept C141071460 @default.
• W2021041107 hasConcept C172680121 @default.
• W2021041107 hasConcept C187212893 @default.
• W2021041107 hasConcept C2776212519 @default.
• W2021041107 hasConcept C2776225084 @default.
• W2021041107 hasConcept C2779134260 @default.
• W2021041107 hasConcept C2779234561 @default.
• W2021041107 hasConcept C2779440204 @default.
• W2021041107 hasConcept C2779969927 @default.
• W2021041107 hasConcept C2910638406 @default.
• W2021041107 hasConcept C54355233 @default.
• W2021041107 hasConcept C71924100 @default.
• W2021041107 hasConcept C86803240 @default.
• W2021041107 hasConceptScore W2021041107C126322002 @default.
• W2021041107 hasConceptScore W2021041107C141071460 @default.
• W2021041107 hasConceptScore W2021041107C172680121 @default.
• W2021041107 hasConceptScore W2021041107C187212893 @default.
• W2021041107 hasConceptScore W2021041107C2776212519 @default.
• W2021041107 hasConceptScore W2021041107C2776225084 @default.
• W2021041107 hasConceptScore W2021041107C2779134260 @default.
• W2021041107 hasConceptScore W2021041107C2779234561 @default.
• W2021041107 hasConceptScore W2021041107C2779440204 @default.
• W2021041107 hasConceptScore W2021041107C2779969927 @default.
• W2021041107 hasConceptScore W2021041107C2910638406 @default.
• W2021041107 hasConceptScore W2021041107C54355233 @default.
• W2021041107 hasConceptScore W2021041107C71924100 @default.
• W2021041107 hasConceptScore W2021041107C86803240 @default.
• W2021041107 hasIssue "6" @default.
• W2021041107 hasLocation W20210411071 @default.
• W2021041107 hasLocation W20210411072 @default.
• W2021041107 hasOpenAccess W2021041107 @default.
• W2021041107 hasPrimaryLocation W20210411071 @default.
• W2021041107 hasRelatedWork W120257721 @default.
• W2021041107 hasRelatedWork W1584581471 @default.
• W2021041107 hasRelatedWork W1997005266 @default.
• W2021041107 hasRelatedWork W2012931293 @default.
• W2021041107 hasRelatedWork W2021041107 @default.
• W2021041107 hasRelatedWork W2027292988 @default.
• W2021041107 hasRelatedWork W3082276934 @default.
• W2021041107 hasRelatedWork W3108690504 @default.
• W2021041107 hasRelatedWork W3137397254 @default.
• W2021041107 hasRelatedWork W4200610496 @default.

• next